Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier
Yongjiu Lv,* Jingjing Li,* Huali Chen, Yan Bai, Liangke Zhang Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing Research Center for Pharmaceutical Engineering, College of Pharmacy, Chongqing Medical University, Chongqing, China *These authors contributed equally to thi...
Guardado en:
Autores principales: | Lv Y, Li J, Chen H, Bai Y, Zhang L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e8f7d655d6764095a10f5518349c1a6d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes
por: Sun Y, et al.
Publicado: (2018) -
Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery
por: Naz S, et al.
Publicado: (2019) -
Mesoporous Silica Nanoparticle-Based Imaging Agents for Hepatocellular Carcinoma Detection
por: Xuqi Peng, et al.
Publicado: (2021) -
Natural material-decorated mesoporous silica nanoparticle container for multifunctional membrane-controlled targeted drug delivery
por: Hu Y, et al.
Publicado: (2017) -
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid
por: Li ZY, et al.
Publicado: (2020)